Armada III Values Brains Bioceutical at $750M in SPAC Deal
PHILADELPHIA, PA — Armada Acquisition Corp. III (Nasdaq: AACI) has agreed to merge with Brains Bioceutical Corp. in a transaction valuing the pharmaceutical manufacturer at approximately $750 million before the …
Armada III Values Brains Bioceutical at $750M in SPAC Deal Read More